BookmarkWASHINGTON: US biotechnology firm Moderna on Monday (Jan 25) said lab studies showed its COVID-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa.But out of caution, the company will test adding a second booster of its vaccine - to make three shots in total - and has begun preclinical studies on a booster specifically for the South African variant after tests showed the vaccine may produce a diminished antibody response.
AdvertisementAdvertisementThe current regimen is for two shots, four weeks apart. The company said in a press release that it was being cautious and that the two-dose regimen of the vaccine was still expected to be protective against the South African and other variants detected to date.
"We are encouraged by these new data, which reinforce our confidence that the Moderna COVID-19 Vaccine should be protective against these newly detected variants," said Stephane Bancel, Moderna's CEO. Read more: CNA »